Cargando…

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease

BACKGROUND: Visinin-like protein-1 (VILIP-1) and chitinase-3-like protein 1 (CHI3L1 or YKL-40) in cerebrospinal fluid (CSF) are newly discovered markers indicating neuronal damage and microglial activation, respectively. Phosphorylated tau (p-tau) reflects the neuropathology of Alzheimer’s disease (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hua, Ng, Kok Pin, Therriault, Joseph, Kang, Min Su, Pascoal, Tharick A., Rosa-Neto, Pedro, Gauthier, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161434/ https://www.ncbi.nlm.nih.gov/pubmed/30311914 http://dx.doi.org/10.1186/s40035-018-0127-7

Ejemplares similares

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimer’s disease patients relative to healthy controls and mild cognitive impairment patients
por: Hu, Xiaohui, et al.
Publicado: (2017)

Divalent Cations and Redox Conditions Regulate the Molecular Structure and Function of Visinin-Like Protein-1
por: Wang, Conan K., et al.
Publicado: (2011)

The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease—old wine in new bottles
por: Braunewell, Karl H.
Publicado: (2012)

Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases
por: Halbgebauer, Steffen, et al.
Publicado: (2022)

Serum Amyloid Beta Precursor Protein, Neurofilament Light, and Visinin-like Protein-1 in Rugby Players: An Exploratory Study
por: Morgan, Jessica E., et al.
Publicado: (2022)

Structure and Calcium Binding Properties of a Neuronal Calcium-Myristoyl Switch Protein, Visinin-Like Protein 3
por: Li, Congmin, et al.
Publicado: (2016)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
por: Ashton, Nicholas J., et al.
Publicado: (2022)

Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer
por: Kzhyshkowska, Julia, et al.
Publicado: (2007)

Visinin-like protein-1 level is associated with short-term functional outcome of acute ischemic stroke: A prospective cohort study
por: Liu, Dengjun, et al.
Publicado: (2020)

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
por: Gauthier, Serge, et al.
Publicado: (2018)

Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling
por: Lee, Chun Geun
Publicado: (2009)

The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases
por: Mack, Ines, et al.
Publicado: (2015)

Chitinase-3-like protein 1 levels in bipolar disorder
por: Sahin, Basak, et al.
Publicado: (2019)

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40
por: Deming, Yuetiva, et al.
Publicado: (2016)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
por: Gobom, Johan, et al.
Publicado: (2022)

In vivo tau staging in Alzheimer’s disease
por: Therriault, Joseph, et al.
Publicado: (2022)

Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes
por: Żurawska-Płaksej, Ewa, et al.
Publicado: (2015)

Chitinase-3 like-protein-1 function and its role in diseases
por: Zhao, Ting, et al.
Publicado: (2020)

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
por: Macedo, Arthur C., et al.
Publicado: (2023)

Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases
por: Kušnierová, Pavlína, et al.
Publicado: (2020)

Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study
por: Tan, Zheren, et al.
Publicado: (2020)

Chitinases and Chitinase-Like Proteins in Obstructive Lung Diseases – Current Concepts and Potential Applications
por: Przysucha, Natalia, et al.
Publicado: (2020)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
por: Tissot, Cécile, et al.
Publicado: (2021)

Differential expression of Chitinase 3‐Like 1 protein in appendicitis and appendix carcinomas
por: Zhang, Yong, et al.
Publicado: (2022)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly
por: Li, Xiaofeng, et al.
Publicado: (2017)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals
por: Lussier, Firoza Z, et al.
Publicado: (2021)

Visinin‐like 1, a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer
por: Tage, Hiroki, et al.
Publicado: (2023)

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
por: Gil-Perotin, Sara, et al.
Publicado: (2019)

Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
por: Wang, Yi-Ting T, et al.
Publicado: (2021)

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022)

Chitinase 3-Like 1 Protein Levels Are Elevated in Schistosoma haematobium Infected Children
por: Appleby, Laura J., et al.
Publicado: (2012)

Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice
por: Jung, Yu Yeon, et al.
Publicado: (2018)

Diagnostic and prognostic value of serum Chitinase 3‐like protein 1 in hepatocellular carcinoma
por: Wang, Shuwei, et al.
Publicado: (2022)

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
por: Therriault, Joseph, et al.
Publicado: (2018)

Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [(18)F]THK5351 uptake in progressive supranuclear palsy
por: Ng, Kok Pin, et al.
Publicado: (2019)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8lputeune4ve65bthr17a4mcgi